Search filters

List of works by Geremia B Bolli

A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study

scientific article published on 12 June 2018

A post-hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus 100 U/mL (Gla-100) over wider nocturnal windows in individuals with type 2 diabetes on a basal-only insulin regimen.

scientific article published on 2 October 2018

Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis

scientific article

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0.

scientific article published on 01 February 2019

Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: A double-blind, randomized, crossover study

article

Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans.

scientific article published in November 2003

Different brain responses to hypoglycemia induced by equipotent doses of the long-acting insulin analog detemir and human regular insulin in humans.

scientific article

Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial

scientific article published on 03 April 2020

Equipotency of insulin glargine 300 U/mL AND 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs

scientific article published on 01 October 2020

Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL

scientific article published on 07 November 2019

Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12-month comparison by concomitant sulphonylurea and/or glinide use

scientific article published on 16 July 2018

Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitus

scientific article published on 22 July 2018

Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-naïve people with type 2 diabetes: a post hoc analysis of the EDITION 3 trial

scientific article published on 21 April 2020

John E. Gerich: Father of Modern Physiology of Glucose Homeostasis, Counterregulation to Hypoglycemia, and Mechanistic Treatment of Diabetes

scientific article published on 01 October 2018

Lower Risk for Severe Hypoglycaemia with Insulin Glargine 300 U/mL vs Glargine 100 U/mL in Participants with Type 1 Diabetes: a Meta-Analysis of 6-Month Phase 3 Clinical Trials

scientific article published on 09 June 2020

Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis

scientific article

Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes

scientific article

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial

scientific article published on 13 August 2018

Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes

scientific article published on 15 February 2007

Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study.

scientific article published on 15 April 2011

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U-300 and Glargine U-100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes

article

Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans.

scientific article published on 13 October 2008

Serum insulin and C-peptide concentration and breast cancer: a meta-analysis

scientific article

Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans.

scientific article published on 26 May 2009

Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus

scientific article published on 01 February 2008

Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin

scientific article published on 01 October 2020

The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications

scientific article published on 03 February 2020

Paulina is supported by:

About Paulina

Help